Peer Review reports
From: Prognostic marker CXCL5 in glioblastoma polyformis and its mechanism of immune invasion
| Original Submission | ||
|---|---|---|
| 19 Apr 2023 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| 19 Aug 2023 | Reviewed | Reviewer Report |
| 19 Aug 2023 | Reviewed | Reviewer Report |
| 23 Aug 2023 | Reviewed | Reviewer Report - Yuting Liu |
| 20 Sep 2023 | Author responded | Author comments - Chen Rui |
| Resubmission - Version 5 | ||
| 20 Sep 2023 | Submitted | Manuscript version 5 |
| 8 Oct 2023 | Author responded | Author comments - Chen Rui |
| Resubmission - Version 6 | ||
| 8 Oct 2023 | Submitted | Manuscript version 6 |
| 9 Oct 2023 | Author responded | Author comments - Chen Rui |
| Resubmission - Version 7 | ||
| 9 Oct 2023 | Submitted | Manuscript version 7 |
| 10 Oct 2023 | Author responded | Author comments - Chen Rui |
| Resubmission - Version 8 | ||
| 10 Oct 2023 | Submitted | Manuscript version 8 |
| 10 Oct 2023 | Author responded | Author comments - Chen Rui |
| Resubmission - Version 9 | ||
| 10 Oct 2023 | Submitted | Manuscript version 9 |
| 11 Oct 2023 | Author responded | Author comments - Chen Rui |
| Resubmission - Version 10 | ||
| 11 Oct 2023 | Submitted | Manuscript version 10 |
| 7 Nov 2023 | Reviewed | Reviewer Report |
| 12 Nov 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 11 | ||
| Submitted | Manuscript version 11 | |
| Publishing | ||
| 17 Nov 2023 | Editorially accepted | |
| 29 Jan 2024 | Article published | 10.1186/s12885-023-11650-3 |
You can find further information about peer review here.